Bioregenx BRGX
OTC BRGX
$0.00 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Bioregenx, Inc. (BRGX) EBITDA Margin (2023 - 2026)

Updated

Bioregenx's EBITDA Margin came in at -8.64% for Q1 2026, up 26.35 percentage points from -34.99% a year earlier and up 230.63 percentage points from the prior quarter.

Analysis

Bioregenx, Inc. (BRGX) EBITDA Margin (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Bioregenx reported EBITDA Margin of -58.08%, up 728.90 percentage points year-over-year; for FY2025, it was -63.03%, up 814.89 percentage points from FY2024.

  • Going back by year, EBITDA Margin was -877.92% in FY2024 (-778.31 pp) and -99.61% in FY2023.
  • The five-year range for quarterly EBITDA Margin is -3852.94% (Q4 2024) to 41.47% (Q3 2024).
  • Year-over-year, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +76.30 percentage points.
  • The fastest year-over-year change in EBITDA Margin over five years came in Q4 2025 (a gain of 3613.67 percentage points), and the weakest in Q4 2024 (a drop of 3822.13 percentage points).
  • Business Quant data shows BRGX's EBITDA Margin at -239.27% (Q4 2025), 0.77% (Q3 2025) and -15.67% (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.64%
Dec 31, 2025 -239.27%
Sep 30, 2025 1.16%
Jun 30, 2025 -15.94%
Mar 31, 2025 -34.69%
Dec 31, 2024 -3,849.42%
Sep 30, 2024 42.91%
Jun 30, 2024 -62.19%
Mar 31, 2024 -467.23%
Dec 31, 2023 -30.81%
Sep 30, 2023 -310.35%
Jun 30, 2023 -62.78%
Mar 31, 2023 -16.87%
API Access

Bioregenx, Inc. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BRGX&period=max&api_key=YOUR_API_KEY